v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities    
Net income (loss) $ (4,873) $ 820
Adjustments to reconcile net (loss) / income to net cash (used in) / provided by operating activities:    
Depreciation and amortization 27
Amortization of debt discount 862 406
Stock-based expenses 359 1,428
Gain / (loss) on fair value remeasurement 18,602
Change in fair value of stock-based compensation (778)
Bad debt expense 383 164
Impairment of fixed assets 16
Changes in operating assets and liabilities:    
Accounts receivable, net (29,900)
Inventory 446
Other current assets 24 91,387
Other non-current assets 9
Accounts payable and accrued expenses 1,614 8,664
Other current liabilities 52 (92,154)
Other non-current liabilities 678 115
Operating right to use assets and lease liabilities, net 94
Deferred revenue (2,177)
Total adjustments 4,091 (3,770)
Net cash provided by / (used in) operating activities (782) (2,950)
Net cash used in operating activities - discontinued operations 8
Cash Flows from Investing Activities    
Net cash provided by (used in) investing activities
Net cash provided by investing activities - discontinued operations
Cash Flows from Financing Activities    
Proceeds from notes payable 1,000 4,581
Repayments of notes payable (198) (1,467)
Net cash provided by / (used in) financing activities 802 3,114
Net cash used in financing activities - discontinued operations (20)
Foreign exchange effect on cash and restricted cash 6 2
Net Increase (Decrease) in Cash 26 154
Cash – beginning of period (includes $0.27 million of restricted cash as of March 31, 2026 and 2025) 653 1,786
Cash – end of period (includes $0.27 million of restricted cash as of March 31, 2026 and 2025) 679 1,940
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest 16 1,807
Shares issued for OID 840
Note Payable OID $ 97